Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander

Diabetes mellitus incrementa el riesgo de amputación en miembros inferiores. Se han estudiado diferentes factores de riesgo con el objetivo de establecer asociación con la amputación en pacientes con pie diabético. 2,3,4,5,6,7. El objetivo fue determinar cuáles factores de riesgo se encontraban asoc...

Full description

Autores:
Cepeda Jordan, Ricardo
Tipo de recurso:
http://purl.org/coar/version/c_b1a7d7d4d402bcce
Fecha de publicación:
2016
Institución:
Universidad Industrial de Santander
Repositorio:
Repositorio UIS
Idioma:
spa
OAI Identifier:
oai:noesis.uis.edu.co:20.500.14071/35368
Acceso en línea:
https://noesis.uis.edu.co/handle/20.500.14071/35368
https://noesis.uis.edu.co
Palabra clave:
Pie Diabético
Amputación
Wagner
Hemoglobina
Glicosilado Description:
Introduction. Diabetes mellitus increases the risk of amputation in lower limbs. We have studied different risk factors with the aim of establishing partnership with amputation in patients with diabetic foot. 2
3
4
5
6
7. the objective was to determine which risk factors associated met with amputation in patients with diabetic foot. Hypothesis: patients with hemoglobin-glycosylated > 8% and > 65 years had an increased risk of amputation. Materials and methods. Analytical
observational
cross-sectional study. 72 patients with a diagnosis of diabetic foot supported by emergency room of the University Hospital of Santander 2013 to 2015
follow-up for 6 months. Results. The prevalence of amputation between 2013 to 2015 was 72% with 52 cases
amputation higher (67%) 35 cases
amputation lowest (33%) 17 cases. Amputation in patients > 65 years was associated with the female gender OR 5 CI (1-25) q: 0.039
glycosylatedem hoglobin > 10% OR: 1.6 (1
3-2
1) IC and Wagner v
OR 1.7 IC (1
3-2
2)
with peripheral arterial disease Occlusive OR:4 IC (1
1-14). LLA amputation in patients < 65 years was associated with levels of glycosylated hemoglobin < 6% OR 6.4 CI (1
5-26). levels of glycosylated hemoglobin < 6% were constituted in a protective factor for amputation patients < 65 years OR more: 0.1 IC (0
02-0
4). the proportion of mortality in the Group of amputees was 25% and in the Group of non-amputated 10%. conclusions. Amputation associated with age > 65 years
female gender
glycosylated hemoglobin > 10%
Wagner V
and peripheral arterial Occlusive Disease. Patients come late to the health system with complications of difficult management and advanced stages and glycosylated hemoglobin levels > 10%. These aspects influence survival. Key words: diabetes
complications
diabetic foot and its complications
management
treatment
amputation
Rights
License
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
id UISANTADR2_ae15ae1152243f355428012bca71f14a
oai_identifier_str oai:noesis.uis.edu.co:20.500.14071/35368
network_acronym_str UISANTADR2
network_name_str Repositorio UIS
repository_id_str
dc.title.none.fl_str_mv Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander
dc.title.english.none.fl_str_mv Diabetes Foot, Amputation, Wagner, Hemoglobin, Glycated
title Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander
spellingShingle Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander
Pie Diabético
Amputación
Wagner
Hemoglobina
Glicosilado Description:
Introduction. Diabetes mellitus increases the risk of amputation in lower limbs. We have studied different risk factors with the aim of establishing partnership with amputation in patients with diabetic foot. 2
3
4
5
6
7. the objective was to determine which risk factors associated met with amputation in patients with diabetic foot. Hypothesis: patients with hemoglobin-glycosylated &gt; 8% and &gt; 65 years had an increased risk of amputation. Materials and methods. Analytical
observational
cross-sectional study. 72 patients with a diagnosis of diabetic foot supported by emergency room of the University Hospital of Santander 2013 to 2015
follow-up for 6 months. Results. The prevalence of amputation between 2013 to 2015 was 72% with 52 cases
amputation higher (67%) 35 cases
amputation lowest (33%) 17 cases. Amputation in patients &gt; 65 years was associated with the female gender OR 5 CI (1-25) q: 0.039
glycosylatedem hoglobin &gt; 10% OR: 1.6 (1
3-2
1) IC and Wagner v
OR 1.7 IC (1
3-2
2)
with peripheral arterial disease Occlusive OR:4 IC (1
1-14). LLA amputation in patients &lt; 65 years was associated with levels of glycosylated hemoglobin &lt; 6% OR 6.4 CI (1
5-26). levels of glycosylated hemoglobin &lt; 6% were constituted in a protective factor for amputation patients &lt; 65 years OR more: 0.1 IC (0
02-0
4). the proportion of mortality in the Group of amputees was 25% and in the Group of non-amputated 10%. conclusions. Amputation associated with age &gt; 65 years
female gender
glycosylated hemoglobin &gt; 10%
Wagner V
and peripheral arterial Occlusive Disease. Patients come late to the health system with complications of difficult management and advanced stages and glycosylated hemoglobin levels &gt; 10%. These aspects influence survival. Key words: diabetes
complications
diabetic foot and its complications
management
treatment
amputation
title_short Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander
title_full Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander
title_fullStr Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander
title_full_unstemmed Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander
title_sort Factores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de Santander
dc.creator.fl_str_mv Cepeda Jordan, Ricardo
dc.contributor.advisor.none.fl_str_mv Reyes Nuñez, Victor Arturo
dc.contributor.author.none.fl_str_mv Cepeda Jordan, Ricardo
dc.subject.none.fl_str_mv Pie Diabético
Amputación
Wagner
Hemoglobina
Glicosilado Description:
topic Pie Diabético
Amputación
Wagner
Hemoglobina
Glicosilado Description:
Introduction. Diabetes mellitus increases the risk of amputation in lower limbs. We have studied different risk factors with the aim of establishing partnership with amputation in patients with diabetic foot. 2
3
4
5
6
7. the objective was to determine which risk factors associated met with amputation in patients with diabetic foot. Hypothesis: patients with hemoglobin-glycosylated &gt; 8% and &gt; 65 years had an increased risk of amputation. Materials and methods. Analytical
observational
cross-sectional study. 72 patients with a diagnosis of diabetic foot supported by emergency room of the University Hospital of Santander 2013 to 2015
follow-up for 6 months. Results. The prevalence of amputation between 2013 to 2015 was 72% with 52 cases
amputation higher (67%) 35 cases
amputation lowest (33%) 17 cases. Amputation in patients &gt; 65 years was associated with the female gender OR 5 CI (1-25) q: 0.039
glycosylatedem hoglobin &gt; 10% OR: 1.6 (1
3-2
1) IC and Wagner v
OR 1.7 IC (1
3-2
2)
with peripheral arterial disease Occlusive OR:4 IC (1
1-14). LLA amputation in patients &lt; 65 years was associated with levels of glycosylated hemoglobin &lt; 6% OR 6.4 CI (1
5-26). levels of glycosylated hemoglobin &lt; 6% were constituted in a protective factor for amputation patients &lt; 65 years OR more: 0.1 IC (0
02-0
4). the proportion of mortality in the Group of amputees was 25% and in the Group of non-amputated 10%. conclusions. Amputation associated with age &gt; 65 years
female gender
glycosylated hemoglobin &gt; 10%
Wagner V
and peripheral arterial Occlusive Disease. Patients come late to the health system with complications of difficult management and advanced stages and glycosylated hemoglobin levels &gt; 10%. These aspects influence survival. Key words: diabetes
complications
diabetic foot and its complications
management
treatment
amputation
dc.subject.keyword.none.fl_str_mv Introduction. Diabetes mellitus increases the risk of amputation in lower limbs. We have studied different risk factors with the aim of establishing partnership with amputation in patients with diabetic foot. 2
3
4
5
6
7. the objective was to determine which risk factors associated met with amputation in patients with diabetic foot. Hypothesis: patients with hemoglobin-glycosylated &gt; 8% and &gt; 65 years had an increased risk of amputation. Materials and methods. Analytical
observational
cross-sectional study. 72 patients with a diagnosis of diabetic foot supported by emergency room of the University Hospital of Santander 2013 to 2015
follow-up for 6 months. Results. The prevalence of amputation between 2013 to 2015 was 72% with 52 cases
amputation higher (67%) 35 cases
amputation lowest (33%) 17 cases. Amputation in patients &gt; 65 years was associated with the female gender OR 5 CI (1-25) q: 0.039
glycosylatedem hoglobin &gt; 10% OR: 1.6 (1
3-2
1) IC and Wagner v
OR 1.7 IC (1
3-2
2)
with peripheral arterial disease Occlusive OR:4 IC (1
1-14). LLA amputation in patients &lt; 65 years was associated with levels of glycosylated hemoglobin &lt; 6% OR 6.4 CI (1
5-26). levels of glycosylated hemoglobin &lt; 6% were constituted in a protective factor for amputation patients &lt; 65 years OR more: 0.1 IC (0
02-0
4). the proportion of mortality in the Group of amputees was 25% and in the Group of non-amputated 10%. conclusions. Amputation associated with age &gt; 65 years
female gender
glycosylated hemoglobin &gt; 10%
Wagner V
and peripheral arterial Occlusive Disease. Patients come late to the health system with complications of difficult management and advanced stages and glycosylated hemoglobin levels &gt; 10%. These aspects influence survival. Key words: diabetes
complications
diabetic foot and its complications
management
treatment
amputation
description Diabetes mellitus incrementa el riesgo de amputación en miembros inferiores. Se han estudiado diferentes factores de riesgo con el objetivo de establecer asociación con la amputación en pacientes con pie diabético. 2,3,4,5,6,7. El objetivo fue determinar cuáles factores de riesgo se encontraban asociados con la amputación en pacientes con pie diabético. Hipótesis: pacientes con hemoglobina glicosilada > 8% y > 65 años tenían un mayor riesgo de amputación. Materiales y métodos. Estudio analítico, observacional, corte transversal. 72 pacientes con diagnóstico de pie diabético admitidos por urgencias del Hospital Universitario de Santander 2013 a 2015,seguimiento por 6 meses . Resultados. La prevalencia de amputación 2013 a 2015 fue de 72% con 52 casos, amputación mayor (67%) 35 casos, amputación menor (33%) 17 casos. La amputación mayor en pacientes > 65 años estuvo asociada con el género femenino OR 5 IC (1-25) p: 0,039, hemoglobina glicosilada > 10% OR: 1,6 IC (1,3-2,1) y a Wagner V, OR 1,7 IC (1,3-2,2), con enfermedad arterial periférica oclusiva OR:4 IC (1,1-14). Lla amputación menor en pacientes < 65 años estuvo asociada a niveles de hemoglobina glicosilada < 6% OR 6,4 IC (1,5-26). Los niveles de hemoglobina glicosilada < 6% se constituyeron en un factor protector para la amputación mayor en pacientes < 65 años OR: 0,1 IC (0,02-0,4). La proporción de mortalidad en el grupo de amputados fue 25% y en el grupo de no amputados 10%. Conclusiones. La amputación se asoció a edad > 65 años, género femenino, hemoglobina glicosilada >10%, Wagner V, y enfermedad arterial periférica oclusiva. Los pacientes acuden de manera tardía al sistema sanitario con complicaciones de difícil manejo y estadios avanzados y niveles de hemoglobina glicosilada > 10%. Estos aspectos influyen en la supervivencia . Palabras clave: diabetes, complicaciones, pie diabético y sus complicaciones, manejo, tratamiento, amputación
publishDate 2016
dc.date.available.none.fl_str_mv 2016
2024-03-03T22:48:17Z
dc.date.created.none.fl_str_mv 2016
dc.date.issued.none.fl_str_mv 2016
dc.date.accessioned.none.fl_str_mv 2024-03-03T22:48:17Z
dc.type.local.none.fl_str_mv Tesis/Trabajo de grado - Monografía - Pregrado
dc.type.hasversion.none.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.coar.none.fl_str_mv http://purl.org/coar/version/c_b1a7d7d4d402bcce
format http://purl.org/coar/version/c_b1a7d7d4d402bcce
dc.identifier.uri.none.fl_str_mv https://noesis.uis.edu.co/handle/20.500.14071/35368
dc.identifier.instname.none.fl_str_mv Universidad Industrial de Santander
dc.identifier.reponame.none.fl_str_mv Universidad Industrial de Santander
dc.identifier.repourl.none.fl_str_mv https://noesis.uis.edu.co
url https://noesis.uis.edu.co/handle/20.500.14071/35368
https://noesis.uis.edu.co
identifier_str_mv Universidad Industrial de Santander
dc.language.iso.none.fl_str_mv spa
language spa
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by/4.0/
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.license.none.fl_str_mv Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
dc.rights.uri.none.fl_str_mv http://creativecommons.org/licenses/by-nc/4.0
dc.rights.creativecommons.none.fl_str_mv Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
rights_invalid_str_mv Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
http://creativecommons.org/licenses/by/4.0/
http://creativecommons.org/licenses/by-nc/4.0
Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad Industrial de Santander
dc.publisher.faculty.none.fl_str_mv Facultad de Salud
dc.publisher.program.none.fl_str_mv Especialización en Ortopedia y Traumatología
dc.publisher.school.none.fl_str_mv Escuela de Medicina
publisher.none.fl_str_mv Universidad Industrial de Santander
institution Universidad Industrial de Santander
bitstream.url.fl_str_mv https://noesis.uis.edu.co/bitstreams/e0cae3a1-7a86-4ad3-b75d-c26ba9fae33a/download
https://noesis.uis.edu.co/bitstreams/38f386c6-b6aa-4d4a-9b1e-0a640804f655/download
https://noesis.uis.edu.co/bitstreams/42b95551-f55f-4891-81d0-41505b510f10/download
bitstream.checksum.fl_str_mv f0796fd4707cf94f6807ee1c4c03300d
65b16e1c9f4e7a16aeb4277cc657612c
5e7201c300a198980b4c9ba15bae2e6d
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv DSpace at UIS
repository.mail.fl_str_mv noesis@uis.edu.co
_version_ 1814095170983952384
spelling Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)http://creativecommons.org/licenses/by/4.0/http://creativecommons.org/licenses/by-nc/4.0Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)http://purl.org/coar/access_right/c_abf2Reyes Nuñez, Victor ArturoCepeda Jordan, Ricardo2024-03-03T22:48:17Z20162024-03-03T22:48:17Z20162016https://noesis.uis.edu.co/handle/20.500.14071/35368Universidad Industrial de SantanderUniversidad Industrial de Santanderhttps://noesis.uis.edu.coDiabetes mellitus incrementa el riesgo de amputación en miembros inferiores. Se han estudiado diferentes factores de riesgo con el objetivo de establecer asociación con la amputación en pacientes con pie diabético. 2,3,4,5,6,7. El objetivo fue determinar cuáles factores de riesgo se encontraban asociados con la amputación en pacientes con pie diabético. Hipótesis: pacientes con hemoglobina glicosilada > 8% y > 65 años tenían un mayor riesgo de amputación. Materiales y métodos. Estudio analítico, observacional, corte transversal. 72 pacientes con diagnóstico de pie diabético admitidos por urgencias del Hospital Universitario de Santander 2013 a 2015,seguimiento por 6 meses . Resultados. La prevalencia de amputación 2013 a 2015 fue de 72% con 52 casos, amputación mayor (67%) 35 casos, amputación menor (33%) 17 casos. La amputación mayor en pacientes > 65 años estuvo asociada con el género femenino OR 5 IC (1-25) p: 0,039, hemoglobina glicosilada > 10% OR: 1,6 IC (1,3-2,1) y a Wagner V, OR 1,7 IC (1,3-2,2), con enfermedad arterial periférica oclusiva OR:4 IC (1,1-14). Lla amputación menor en pacientes < 65 años estuvo asociada a niveles de hemoglobina glicosilada < 6% OR 6,4 IC (1,5-26). Los niveles de hemoglobina glicosilada < 6% se constituyeron en un factor protector para la amputación mayor en pacientes < 65 años OR: 0,1 IC (0,02-0,4). La proporción de mortalidad en el grupo de amputados fue 25% y en el grupo de no amputados 10%. Conclusiones. La amputación se asoció a edad > 65 años, género femenino, hemoglobina glicosilada >10%, Wagner V, y enfermedad arterial periférica oclusiva. Los pacientes acuden de manera tardía al sistema sanitario con complicaciones de difícil manejo y estadios avanzados y niveles de hemoglobina glicosilada > 10%. Estos aspectos influyen en la supervivencia . Palabras clave: diabetes, complicaciones, pie diabético y sus complicaciones, manejo, tratamiento, amputaciónEspecializaciónEspecialista en Ortopedia y TraumatologíaRisk factors associated with amputation in patients with diabetic foot in santander university hospitalapplication/pdfspaUniversidad Industrial de SantanderFacultad de SaludEspecialización en Ortopedia y TraumatologíaEscuela de MedicinaPie DiabéticoAmputaciónWagnerHemoglobinaGlicosilado Description:Introduction. Diabetes mellitus increases the risk of amputation in lower limbs. We have studied different risk factors with the aim of establishing partnership with amputation in patients with diabetic foot. 234567. the objective was to determine which risk factors associated met with amputation in patients with diabetic foot. Hypothesis: patients with hemoglobin-glycosylated &gt; 8% and &gt; 65 years had an increased risk of amputation. Materials and methods. Analyticalobservationalcross-sectional study. 72 patients with a diagnosis of diabetic foot supported by emergency room of the University Hospital of Santander 2013 to 2015follow-up for 6 months. Results. The prevalence of amputation between 2013 to 2015 was 72% with 52 casesamputation higher (67%) 35 casesamputation lowest (33%) 17 cases. Amputation in patients &gt; 65 years was associated with the female gender OR 5 CI (1-25) q: 0.039glycosylatedem hoglobin &gt; 10% OR: 1.6 (13-21) IC and Wagner vOR 1.7 IC (13-22)with peripheral arterial disease Occlusive OR:4 IC (11-14). LLA amputation in patients &lt; 65 years was associated with levels of glycosylated hemoglobin &lt; 6% OR 6.4 CI (15-26). levels of glycosylated hemoglobin &lt; 6% were constituted in a protective factor for amputation patients &lt; 65 years OR more: 0.1 IC (002-04). the proportion of mortality in the Group of amputees was 25% and in the Group of non-amputated 10%. conclusions. Amputation associated with age &gt; 65 yearsfemale genderglycosylated hemoglobin &gt; 10%Wagner Vand peripheral arterial Occlusive Disease. Patients come late to the health system with complications of difficult management and advanced stages and glycosylated hemoglobin levels &gt; 10%. These aspects influence survival. Key words: diabetescomplicationsdiabetic foot and its complicationsmanagementtreatmentamputationFactores de riesgo asociados a amputación en pacientes con pie diabético en el Hospital Universitario de SantanderDiabetes Foot, Amputation, Wagner, Hemoglobin, GlycatedTesis/Trabajo de grado - Monografía - Pregradohttp://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/version/c_b1a7d7d4d402bcceORIGINALCarta de autorización.pdfapplication/pdf143834https://noesis.uis.edu.co/bitstreams/e0cae3a1-7a86-4ad3-b75d-c26ba9fae33a/downloadf0796fd4707cf94f6807ee1c4c03300dMD51Documento.pdfapplication/pdf1590114https://noesis.uis.edu.co/bitstreams/38f386c6-b6aa-4d4a-9b1e-0a640804f655/download65b16e1c9f4e7a16aeb4277cc657612cMD52Nota de proyecto.pdfapplication/pdf154655https://noesis.uis.edu.co/bitstreams/42b95551-f55f-4891-81d0-41505b510f10/download5e7201c300a198980b4c9ba15bae2e6dMD5320.500.14071/35368oai:noesis.uis.edu.co:20.500.14071/353682024-03-03 17:48:17.923http://creativecommons.org/licenses/by-nc/4.0http://creativecommons.org/licenses/by/4.0/open.accesshttps://noesis.uis.edu.coDSpace at UISnoesis@uis.edu.co